Publication: May 2025
Report Type: Tracker
Report Format: PDF DataSheet
Report ID: MD4921 
  Pages: 110+
 

Oman Medical Device Market Size and Forecast by Device Type, Patient Demographics, Distribution Channel, and End User: 2019-2033

Report Format: PDF DataSheet |   Pages: 110+  

 May 2025  | 

Oman Medical Device Market Outlook

Gears Up for Digital Healthcare Expansion

The Oman medical device market is entering a new phase of growth, driven by national health reforms, strategic investments, and the rising integration of smart technologies in care delivery. As of 2024, the market was valued at approximately US$ XX million and is projected to grow to US$ X.2 billion by 2033, registering a CAGR of X.4% over the forecast period. The Oman medical device industry is underpinned by Vision 2040, which places strong emphasis on enhancing healthcare access, digitization, and local manufacturing. Notably, the Ministry of Health (MoH) has ramped up its digital health initiatives, with eHealth platforms and telemedicine now facilitating remote diagnostics and chronic disease management. The nation’s medical service spending continues to rise, exceeding OMR 1.3 billion (US$ 3.38 billion) in 2023, reflecting the government's commitment to advancing health infrastructure. Although Oman remains largely dependent on imported devices, favorable regulations and free trade zones such as Salalah and Duqm are creating opportunities for regional distributors and global manufacturers to establish localized operations. With increasing healthcare tourism from neighboring Gulf countries, the Oman medical device sector is well-positioned to become a regional medtech growth node.

 

Key Drivers Shaping Industry Growth

Several core factors are propelling the Oman medical device industry forward. Firstly, the government’s commitment to healthcare modernization under Vision 2040 and the National Health Policy (2020–2040) emphasizes digital transformation, preventive healthcare, and public-private partnerships. The MoH has significantly expanded infrastructure development, including 10 new hospitals and over 25 primary care centers planned for completion by 2026. The aging population and rising prevalence of chronic diseases—diabetes affects 15% of Omani adults—have led to increased demand for devices such as insulin pumps, continuous glucose monitors, and portable ECGs. Additionally, the country’s push for medical device spending in homecare solutions is evident in the introduction of subsidized remote patient monitoring kits in 2023 by the MoH and regional health authorities. Oman's alignment with Gulf Cooperation Council (GCC) Unified Medical Device Regulations enhances device importation efficiency and ensures quality standards. The presence of Special Economic Zones (SEZs) with tax exemptions is also attracting foreign direct investment in device assembly and packaging. Combined, these factors are fostering a proactive and stable investment climate across the Oman medical device sector, offering fertile ground for scalable growth in the coming decade.

Medtech Adoption Trends: From Institutional Integration to Consumer-Driven Devices

Medical device adoption in Oman is shifting from traditional procurement to technology-driven and patient-centric approaches. Hospitals such as The Royal Hospital, Sultan Qaboos University Hospital, and Al Nahdha Hospital have upgraded their equipment inventories with digital radiography systems, laparoscopic devices, and AI-assisted diagnostic tools. In Q3 2023, The Royal Hospital piloted robotic-assisted surgery for urology cases, making it one of the first public institutions in the country to do so. Moreover, the use of portable diagnostics has surged in rural health centers, where mobile ultrasound and rapid diagnostic kits are improving maternal and child health outcomes. On the consumer front, the popularity of wearable health devices such as smartwatches with heart monitoring functions and wireless pulse oximeters has grown, particularly among younger demographics. Pharmacies such as Muscat Pharmacy, Al Hashar Pharmacy, and City Pharmacy now offer a wide range of digital devices, supported by omnichannel models with delivery and subscription options. The expansion of health insurance coverage and private-sector clinics, such as Starcare and Aster Oman, is also fostering medtech integration. These evolving patterns point to a promising future for the Oman medical device market, where clinical excellence and digital innovation are beginning to converge.

Trade, Workforce, Infrastructure, and Localization Readiness

Understanding the momentum of the Oman medical device sector requires analyzing key industry indicators. Oman’s medtech market is still predominantly reliant on imports, with over 85% of devices sourced internationally, primarily from Germany, the U.S., and China, as per 2023 customs data. However, the presence of local assembly operations in SEZs—particularly for low-cost consumables and diagnostic kits—is gradually improving the localization ratio. The country's medical device spending per capita is rising steadily, supported by improved public healthcare budgeting and increased procurement flexibility. Infrastructure-wise, Oman has a strong logistics backbone—ranked favorably in the World Bank's Logistics Performance Index—enabling timely delivery of cold-chain-dependent and high-value equipment. Human capital, especially biomedical engineers and certified technicians, is being cultivated through collaborations between MoH and local universities such as Sultan Qaboos University. Despite these strengths, challenges remain in research funding and raw material availability for high-end manufacturing. Nevertheless, government incentives, improved data interoperability through the Al Shifa eHealth system, and growing private sector demand collectively form a solid foundation for a sustainable and expanding Oman medical device industry over the next decade.

Players and Channels: International Giants, Regional Distributors, and Local Innovators

The Oman medical device market is composed of a multi-tiered value chain with international OEMs, regional distributors, and emerging local players shaping the landscape. Global firms such as Siemens Healthineers, Philips, GE HealthCare, and Medtronic dominate the imaging, diagnostics, and cardiology segments. In January 2024, GE HealthCare partnered with Sultan Qaboos University Hospital to introduce AI-enabled imaging analytics, reinforcing its long-term regional strategy. Regional distributors like Al Farsi Medical Supplies, LifeLine Medical, and Al Nab’a Supplies act as intermediaries, offering supply chain services, device maintenance, and hospital training programs. On the local front, startups such as OmanMed Solutions and BioSmart are gaining ground in telehealth peripherals and diagnostic software, often supported by Oman Technology Fund and university-led incubators. Retail pharmacies and e-commerce platforms are expanding their device categories to include portable ECGs, fetal dopplers, and CPAP machines, targeting both chronic and preventive care segments. This hybrid model—powered by global expertise, regional distribution agility, and local customization—is positioning the Oman medical device sector as a diverse and increasingly resilient ecosystem ready to meet both domestic and Gulf-wide healthcare needs.

 

Author: Mahesh Y (Asst. Manager – Healthcare and Medical Device)


 

*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation. [Learn more]

 

 

Oman Medical Device Market Segmentation

 



*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation. [Learn more]